A detailed history of Sanctuary Advisors, LLC transactions in Grifols Sa stock. As of the latest transaction made, Sanctuary Advisors, LLC holds 41,834 shares of GRFS stock, worth $364,374. This represents 0.0% of its overall portfolio holdings.

Number of Shares
41,834
Previous 42,725 2.09%
Holding current value
$364,374
Previous $386 Million 22.99%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Jan 06, 2026

SELL
$8.87 - $10.85 $7,903 - $9,667
-891 Reduced 2.09%
41,834 $297 Million
Q2 2025

Jan 06, 2026

BUY
$6.49 - $9.09 $5,782 - $8,099
891 Added 2.13%
42,725 $386 Million
Q1 2025

Jan 06, 2026

BUY
$6.62 - $8.71 $29,909 - $39,351
4,518 Added 12.11%
41,834 $297 Million
Q4 2024

Jan 31, 2025

BUY
$6.99 - $9.55 $9,995 - $13,656
1,430 Added 3.98%
37,316 $258 Million
Q3 2024

Nov 25, 2024

BUY
$6.28 - $9.38 $225,364 - $336,610
35,886 New
35,886 $312 Million

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $5.91B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Sanctuary Advisors, LLC Portfolio

Follow Sanctuary Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sanctuary Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sanctuary Advisors, LLC with notifications on news.